Trials / Completed
CompletedNCT05913479
Evaluation of the Efficacy and Safety of Mucogye® Gel as a Moisturizer
HYDRAGYNE (MUCG234) - Evaluation of the Efficacy and Safety of Mucogye® Gel as a Moisturizer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Biocodex · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this post-Market Clinical Follow-up (PMCF) study for a class IIb medical device is to confirm th efficacy and safety of Mucogyne Gel as a moisturizer in women with vaginal dryness irrespective of the cause; when used in accordance with its approved labelling.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Mucogyne Gel | At inclusion visit (V0), the Investigator will ask the subject to apply MUCOGYNE® Gel as described in the Instructions For Use, i.e., internally, one application 2 to 3 times a week until symptoms improve during 5 weeks (D35 +/- 3) |
Timeline
- Start date
- 2023-10-10
- Primary completion
- 2026-01-02
- Completion
- 2026-01-02
- First posted
- 2023-06-22
- Last updated
- 2026-02-19
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05913479. Inclusion in this directory is not an endorsement.